Sort
30,917 grants matching “tumor microenvironment”
Immune Checkpoint Blockade Targeting the Novel PSGL-1/VISTA Axis for Pancreatic Cancer
$268,345Linda Mac Pherson Bradley · Sanford Burnham Prebys Medical Discovery Institute · R21 · FY2025 · CA
Radiation Res & Translational Biology
$268,331Richard G Pestell · Thomas Jefferson University · P30 · FY2013 · CA
Novel Targets for Protection of T Cells From Tumor-Induced Dysfunction
$268,298Hannah Rabinowich · University Of Pittsburgh At Pittsburgh · R01 · FY2007 · CA
Proteasome Inhibition in Myelodysplastic Syndromes
$268,104Jane L Liesveld · University Of Rochester · R21 · FY2006 · CA
Project 2- The ISR effector ATF4 in metabolic reprogramming and survival during Myc-induced tumorigenesis
$268,099Constantinos Koumenis · University Of Pennsylvania · P01 · FY2022 · CA
In vivo testing of an agonistic anti-GITR mAb that induces cell surface clustering to augment signal transduction and a 2nd Gen bispecific anti-GITR/PD1 Ab derivative for improved anti-tumor activity
$268,059Wayne A. Marasco · Dana-Farber Cancer Inst · R21 · FY2024 · CA
CSF-1R Signaling Pathways Regulating macrophage chemotaxis and angiogenic fac rel
$268,048E Richard Stanley · Albert Einstein College Of Medicine · P01 · FY2011 · CA
Novel Targets for Protection of T Cells From Tumor-Induced Dysfunction
$268,039Hannah Rabinowich · University Of Pittsburgh At Pittsburgh · R01 · FY2008 · CA
Core C: Comparative Pathology Core
$268,026Enrico Radaelli · University Of Pennsylvania · P01 · FY2024 · CA
Tumor Microenvironment/Angiogenesis Training Grant
$268,004Debabrata Mukhopadhyay · Mayo Clinic Rochester · T32 · FY2012 · CA
PARACEST Agents for Molecular Imaging of Cancer by MRI
$267,977A. Dean Sherry · Ut Southwestern Medical Center · R01 · FY2015 · CA
Project 4
$267,959Peter C Lucas · Mayo Clinic Rochester · P50 · FY2025 · CA
Angiogenic biomarker discovery to direct bevacizumab therapy in cervical cancer - Blood-based Angiome Profiling: An ancillary analysis of GOG-0240
$267,952Angeles Alvarez Secord · Duke University · R21 · FY2021 · CA
CSF-1R Signaling Pathways Regulating macrophage chemotaxis and angiogenic fac rel
$267,905E Richard Stanley · Albert Einstein College Of Medicine · P01 · FY2010 · CA
Safety and Efficacy of Vemurafenib and High-Dose InterferonAlpha-2b for Advanced Melanoma
$267,874Soldano Ferrone · University Of Pittsburgh At Pittsburgh · P50 · FY2015 · CA
Overcoming Tumor Evasion in EBV+ve Lymphomas
$267,813Cliona M Rooney · Baylor College Of Medicine · P50 · FY2020 · CA
Quantitative analysis of epithelial cell scatter
$267,804Anand R Asthagiri · Northeastern University · R01 · FY2010 · CA
Novel Targets for Protection of T Cells From Tumor-Induced Dysfunction
$267,772Hannah Rabinowich · University Of Pittsburgh At Pittsburgh · R01 · FY2009 · CA
The role of immunosuppression in the tumor microenvironment in Hispanic/Latino patients with breast cancer
$267,770Evanthia Theodosiou Roussos Torres · University Of Southern California · P20 · FY2025 · CA
Normal and UV-Induced cutaneous antigen presenting cells
$267,750Case Western Reserve University · R01 · FY2003 · AI
Integrating Genomic and Epigenomic Alterations in Cancer and its Microenvironment
$267,721Charis Eng · Ohio State University · U54 · FY2007 · CA
Therapy-induced Damage to the Host Bone Marrow as a Promoter of Treatment Resistance in Multiple Myeloma
$267,665Carolina Schinke · Univ Of Arkansas For Med Scis · P20 · FY2022 · GM
Pharmacologic and Genomic Imaging Core
$267,656Mario Luca Suva · Brigham And Women'S Hospital · U19 · FY2021 · CA
Regulation of Desmosomal Cadherins in Oral Cancer
$267,582Kathleen Janee Green · Northwestern University At Chicago · R01 · FY2006 · CA
PARACEST Agents for Molecular Imaging of Cancer by MRI
$267,556A. Dean Sherry · Ut Southwestern Medical Center · R01 · FY2012 · CA